Abstract
The addition of different amounts of hydroxyapatite crystals (HAP) to a solution, metastably supersaturated with respect to calcium oxalate (CaOx) resulted in heterogenous crystallization at seed concentrations exceeding 0.2 mmol/l. The induction period varied between 1 and more than 8 h with the shortest period for a seed concentration of 2 mmol/l. Addition to the system of 1 and 2% of whole urine and citrate in concentrations corresponding to approximately 1% of that found in normal urine inhibited the crystallization for as long as 4 h. In a system supersaturated with respect to calcium phosphate (CaP) the total number of crystals was markedly reduced by citrate concentrations exceeding 0.5 mmol/l. The fractions of medium sized and large crystals were sharply reduced and small crystals predominated at higher citrate concentrations. This might indicate effects of citrate on both crystal growth and crystal aggregation. We conclude that increased citrate concentrations during treatment with alkali leads to a significant inhibition of CaOx growth on HAP as well as to a prevention of the formation of large CaP crystals from solutions supersaturated with respect to CaP.
MeSH Terms
Calcium Oxalate/antagonists & inhibitors,urine
Calcium Phosphates/antagonists & inhibitors,urine
Citrates/pharmacology
Citric Acid
Crystallization
Durapatite
Humans
Hydroxyapatites/pharmacology
Time Factors
Urinary Calculi/urine
Chemicals
Calcium Phosphates
Citrates
Hydroxyapatites
alpha-tricalcium phosphate
tetracalcium phosphate
Calcium Oxalate
Citric Acid
calcium phosphate, monobasic, anhydrous
Durapatite
calcium phosphate
calcium phosphate, dibasic, anhydrous
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Berg C
Department of Urology, University Hospital, Linköping, Sweden.
Tiselius H G
References (13)
13 references, click to expand
-
Crystallographic studies on the formation of renal calculi.
Biochem J. 1971 Mar;122(1):6P-7P
PMID: 5124816
-
Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.
Invest Urol. 1981 Mar;18(5):358-63
PMID: 7203960
-
The growth of hydroxyapatite crystals.
Arch Oral Biol. 1970 Aug;15(8):731-45
PMID: 5272549
-
Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.
Urol Int. 1983;38(3):179-81
PMID: 6868215
-
Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system.
Clin Sci Mol Med. 1975 Nov;49(5):369-74
PMID: 1192695
-
Composition of urinary calculi by x-ray diffraction. Collected data from various localities. II. Czechoslovakia.
Br J Urol. 1968 Aug;40(4):402-11
PMID: 5678161
-
EQUIL2: a BASIC computer program for the calculation of urinary saturation.
J Urol. 1985 Dec;134(6):1242-4
PMID: 3840540
-
Long-term treatment of calcium nephrolithiasis with potassium citrate.
J Urol. 1985 Jul;134(1):11-9
PMID: 3892044
-
Epitaxial relationships in urolithiasis: the brushite-whewellite system.
Clin Sci Mol Med. 1977 Feb;52(2):143-8
PMID: 844247
-
The effect of pH on the risk of calcium oxalate crystallization in urine.
Eur Urol. 1986;12(1):59-61
PMID: 3948899
-
Epitaxy as a growth factor in urinary calculi and gallstones.
Nature. 1968 Jan 6;217(5123):56-8
PMID: 5635632
-
Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
Lancet. 1986 May 10;1(8489):1056-8
PMID: 2871335
-
Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples.
Clin Chem. 1981 Apr;27(4):565-8
PMID: 7471423